Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Compounds containing an unfused pyridine ring in the structure, nesoi
Heterocyclic compounds with nitrogen hetero-ato (s) only with an unfused pyridine ring, hydrogenated or not
Chemicals-organic
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $7.78 to $12.96.. | |
Does NSN 6810-00-242-3642 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Army, Department Of The Navy, and Brazil | |
What is the NIIN of NSN 6810-00-242-3642? | |
002423642 or 00-242-3642 | |
Does NSN 6810-00-242-3642 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6810-00-242-3642? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Jan 01, 1963 |
Ld50 lc50 mixture: oral ld50 (rat) is 1200 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: inhalation/ingestion/skin
absorption-all produce methemoglobin in blood, causing reduced
blood function. Eye contact may cause irritation. Chronic:
prolonged or repeated exposure may affect li ver, central nervous
system, and bone marrow; weight loss, anemia, and irritability may
also occur.
explanation of carcinogenicity: 8-hydroquinoline is not listed by iarc
and ntp due a lack of sufficient evidence (class 3 iarc) .
effects of overexposure: ingested/inhaled/skin contact: headache,
cyanosis, shallow breathing, dizziness, confusion, lethargy,
stupor, convulsions, coma, jaundice, pain in urination, anemia,
death. Eye: redness, tearing, blur red vision.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: inhaled: move to fresh air. Give artificial respiration if
breathing stopped. Give oxygen if breathing difficult. See doctor.
eyes: flush with lots of water for 15 minutes or until no residue
remains. see doctor. Skin: remove contaminated clothes. Wash with
soap and water. Ingested: if conscious, induce vomiting by giving
syrup of ipecac, followed by water. Treat symptomatically and
supportively.
Hcc: t6
boiling pt: b.P. Text: 512f,267c
melt/freeze pt: m.P/f.P text: 167f,75c
decomp temp: decomp text: 512f,267c
spec gravity: 1.0 (water=1)
solubility in water: insoluble
appearance and odor: white crystals or crystalline powder, darkens on
exposure to light
Stability indicator/materials to avoid: yes
none known
stability condition to avoid: none known
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: dispose of in accordance with local, state and
federal regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: 8-hydroxyquinoline (8-quinolinol)
cas: 148-24-3
rtecs #: vc4200000
fraction by wt: 100%
other rec limits: none recommended